Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)

SHE:300016 Revenue

Beijing Beilu Pharmaceutical had revenue of 352.96M CNY in the quarter ending June 30, 2026, with 17.06% growth. This brings the company's total for the last twelve months to 1.29B, up 18.34% year-over-year. In the year 2025, Beijing Beilu Pharmaceutical had annual revenue of 1.21B with 22.54% growth. That makes Beijing Beilu Pharmaceutical the 17,695th largest company in the world by revenue and 3,219th in China.

• Revenue (ttm): 1.29B
• Revenue Growth: +18.34%
• P/S Ratio: 3.64
• Revenue / Employee: 1.09M
• Employees: 1,188
• Market Cap: 4.71B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 348.13M 28.9%
• Overseas 199.87M 16.6%
• North China 190.59M 15.8%
• Central China 136.43M 11.3%
• Southern China 114.57M 9.5%
• Southwest Region 93.68M 7.8%
• Northeast China Region 75.64M 6.3%
• Other 46.36M 3.8%

Fiscal year ended Dec 31, 2025 See the full SHE:300016 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.21B	221.72M	22.54%
Dec 31, 2024	983.55M	92.84M	10.42%
Dec 31, 2023	890.72M	124.84M	16.30%
Jan 1, 2023	765.88M	-94.02M	-10.93%
Jan 1, 2022	859.91M	32.57M	3.94%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error